1. Background {#sec1}
=============

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of women of the reproductive age \[[@B1]\]. Different percentages were obtained in studies on the prevalence of polycystic ovary (PCO) with different definitions. According to the National Institute of Health (NIH), PCO is seen 4--8% worldwide. The incidence of the syndrome is higher according to the criteria of Rotterdam and the Association of Androgen Excess PCOS Society \[[@B2]\]. Because PCO is considered as a group of obese patients, these individuals are often neglected. Therefore, these patients should be carefully evaluated and treated. According to epidemiological data, there are those who are obese and nonobese in width: 20% in the Korean population and 27--50.5% in Europe, and 67% of PCOS in the US are obese. When it comes to different ethnic origins, the prevalence of women with PCOS who are in normal weight and underweight is reported to be 1.5--6.6%. As in our study, subjects with BMI below 25 kg/m^2^ are considered nonobese and BMI over 25 kg/m^2^ is considered obese \[[@B3]\]. However, although the majority of PCOS women is overweight or obese, many lean women with PCOS are also considered at high risk for metabolic disorders such as hyperinsulinemia and insulin resistance. Independent of BMI, this circumstance may lead to some abnormalities such as ovulatory dysfunction and polycystic ovaries and higher intra-abdominal fat \[[@B4]\].

Assessment of human body combination is an important factor for determining the dietary status of an individual and of a group in health and disease \[[@B5]\]. This is important for the evaluation and of the quantity and the distribution of fat mass \[[@B6]\]. Measuring body composition is more useful than measuring body weight gain or weight loss to determine actually whether muscle mass or body fat is increased or lost \[[@B6]\]. Measuring body composition distinguishes fat and fat-free mass which calculating BMI could not \[[@B7]\]. Fat mass differences changed with sex, ethnicity, and age which are influenced by genetic, nutritional status, diet, behaviour, and socioeconomic, environmental, and hormonal factors \[[@B6]\]. If compared with the control group, there is higher waist-to-hip ratio, greater intraperitoneal and visceral fat, and percentages of body fat in BMI-matched lean women with PCO \[[@B3]\]. Android fat pattern is the central in the cardiovascular risk management of metabolic syndrome. Android or central fat deposition is known to be more associated with cardiometabolic risk than gynoid or peripheral fat deposition which is more common in males than females \[[@B8]\]. This type of fat distribution is associated with hyperinsulinemia, impaired glucose tolerance, diabetes mellitus, and increased androgen production rates \[[@B9]\]. Gynoid adiposity is more common in females than men, but is less associated with cardiometabolic risk compared with android adiposity \[[@B10]\]. The android fat pattern has been described in obese and lean women with PCOS \[[@B9]\]. Together, there is conflicting data available about segmental body fat in women with PCOS \[[@B11], [@B12]\].

Studies do not investigate the diet constituents of especially lean PCOS patients. This study also aimed to compare nutritional intakes of lean women with PCOS to the healthy group. It is extremely important for women with PCOS who are lean to get a variety of macro- and micronutrients in their diet; therefore, they need to make sure that their diet contains plenty of vegetables and fruit \[[@B13]\]. The nutrient profile of individuals provides information on the relationship between nutritional intake, nutritional status, and health outcomes \[[@B14]\]. In addition, because lean patients with PCOS do not need to lose weight, they do not need to restrict their caloric intake \[[@B13]\]. Nutrient status in lean individuals with PCOS is also assessed for the first time in this study in our country. Lean women populations with PCOS are a unique group and have different phenotypic, metabolic, hematologic, and neurologic characteristics than obese participants with PCOS \[[@B13]\]. It is necessary to see the profile of Turkey. Some data show that women with PCOS have a nutritional target more prone to consume a carbohydrate-rich diet and a low-fiber diet than matched controls. This observation may be related to the default change of signals such as neuropeptide Y, ghrelin, leptin, and insulin which arise from the brain, intestine, pancreas, and adipose tissue and controls the nutritional behavior \[[@B15]\]. This study compared the nutritional intake of the two groups by using 24-h food record for 3 consecutive days (two weekdays and one weekend).

According to some authors, energy consumption performance could be naturally reduced in polycystic ovary syndrome \[[@B15]\]. Basal metabolic rate (BMR) and active energy expenditure (AEE) are components of total energy expenditure (TEE). AEE called as energy consumption in physical activity. The SenseWear Armband (SWA) is used as a practical tool recently for estimating total energy expenditure and active energy expenditure. Due to the experimental protocols or activities in each study, in the results of specific characteristics of each population and the monitor firmware or the specific characteristics of each population, there is a great heterogeneity for the validity and precision of the SWA in energy expenditure estimation \[[@B16]\]. According to Fruin and Rankin \[[@B17]\], this validated tool has many advantages in clinical use compared to traditional ways as it gives more comfort to patients, costs lower, and gives fast collection of data \[[@B15], [@B17]\]. SWA has not been used in lean PCOS patients so far.

To this purpose, the present study has investigated differences and the possible associations between nutritional intake in accumulation and distribution of body fat and energy expenditure with SWA equipment in lean women with PCOS and compared them with that of healthy group matched for age and BMI.

2. Materials and Methods {#sec2}
========================

2.1. Subjects {#sec2.1}
-------------

32 subsequent subjects with polycystic ovary syndrome and 31 age- and BMI-matched healthy controls were collected for the study who attended the Endocrinology and Metabolism outpatient clinic of Hacettepe University between the year 2011 and 2013. All included women fulfilled the Rotterdam criteria \[[@B18]\].

Exclusion criteria were women with chronic diseases and presence of renal, type 2 diabetes, and cardiovascular or hepatic disease. Before enrollment to this study, none of the subjects ingested any medication for a duration of at least three months. Patients remained in their routine nutritional plan during the study.

2.2. Anthropometrics and Segmental Body Composition {#sec2.2}
---------------------------------------------------

Weight and height were measured with standard techniques. Women were weighed in underwear with a precision weighing of 0.1 kg, and height measurements were recorded with a precision measuring device up to 0.5 cm (Seca 703, Germany). BMI (weight (kilograms)/height (meters)^2^) was calculated. The BMI classification was made in accordance with the World Health Organization \[[@B19]\].

BMR (kcal), total fat mass (FM), total body water (TBW), fat-free mass (FFM), impedance (Ὡ), and segmental measures were predicted by using the BIA Segmental Body Analysis Monitor system (TANITA, BC-418 MA type). Units were calculated both in kilograms and percentages. BIA calculates and predicts the BMR. BIA is used as a method to conduct electricity between fat and water components, based on the conduction of electric current and differences in the body\'s ability. Before measurements, the subjects were instructed to avoid food intake for 4 h and strenuous exercise for 24 h. Measurements were made at room temperature, and the subjects were not allowed to wear metal objects. Dehydration and/or menstrual conditions were the exclusion criteria that changed the body fluid-electrolyte balance.

2.3. Energy and Nutrient Intake and Food Patterns {#sec2.3}
-------------------------------------------------

Questions were about general features, anthropometric measurements, and 3-day food consumption. All the questionnaires were conducted face-to-face by the researcher. Food intake record was assessed by a 24-h dietary record for 3 sequential days by using an Atlas of food photos showing portion sizes \[[@B20]\]. Dietary assessment was made at the beginning of the study. Dietary records for total micro- and macronutrient intake were analyzed with the software according to the standard food tables \[[@B21]\].

2.4. TEE {#sec2.4}
--------

Parameters for total energy expenditure (TEE), physical activity duration (PAD), sleep duration, activity energy expenditure (AEE), average METs, and number of steps (NS) were determined for three days by SenseWear Armband (Body Media Inc., Pittsburg, PA, USA). Armband Metabolic Holter was used in order to determine the level of physical activity (PA) \[[@B22]\]. The subjects were given the SenseWear 6.1 brand Armband (SW-BodyMedia, Pittsburg, USA) for three sequential days on the left arm at each of the three phases in which food consumption was taken. Armband was not inserted during bath. Data are determined by the relevant software program, and the PA states of the individuals were determined. The temperature sensors on the armband detect the temperature changes in the body, the motion sensors detect the activity moment, and the stress sensors measure the skin stress. During the lifetime of the device, subjects did not participate in any PA other than mandatory daily activities. At the end of the measurement, average daily parameters were evaluated \[[@B23]\].

2.5. Statistical Analysis {#sec2.5}
-------------------------

NCSS (Number Cruncher Statistical System) 2007 (Kaysville, Utah, USA) was used for statistical analysis. Normal distribution of quantitative data and descriptive statistics was compared by Student\'s *t* test. Importance was assessed at *p* \< 0.01 and *p* \< 0.05.

3. Results {#sec3}
==========

Age, height, weight, BMI, and BMR measures of the groups were insignificant (*p* \> 0.05) ([Table 1](#tab1){ref-type="table"}).

FM (%) measurements, TBW, and impedance measurements did not show statistically significant differences between the groups (*p* \> 0.05). FM (kg) of the PCOS group was higher than the control group (*p*=0.050; *p* \< 0.05). It was found that the FFM (kg) of the PCOS group was higher, but it was not statistically important (*p*=0.058; *p* \> 0.05) ([Table 2](#tab2){ref-type="table"}).

The right leg fat mass measurement of the PCOS group was higher when compared to the control group (*p* \< 0.05). It was found that the PCOS group was also significantly higher in the right arm fat percentages (*p* \< 0.05). Right arm fat mass measurement of the PCOS group was higher (*p* \< 0.05) ([Table 3](#tab3){ref-type="table"}).

Total energy expenditure, active energy expenditure, steps, sleep duration, average METs, inserting duration, and energy parameter measurements did not show statistically significant difference according to groups (*p* \> 0.05). Physical activity duration measurement (*p* \< 0.01), active energy expenditure measurement (*p* \< 0.05), and step measurement of the PCOS group were significantly lower (*p* \< 0.05) than the control ([Table 4](#tab4){ref-type="table"}).

According to the groups, energy intake, water, protein, fat, carbohydrate, dietary fiber, and dietary cholesterol intake measurements did not show any important difference (*p* \> 0.05). The percentage of protein consumed by the PCOS group was statistically lower than the compared group (*p*=0.008; *p* \< 0.01) ([Table 5](#tab5){ref-type="table"}).

Vitamin A, vitamin C, vitamin E, vitamin B~1~, vitamin B~2~, vitamin B~6,~ total folic acid, *β*-carotene, and Na, K, P, Ca, Mg, Fe, and zinc measurements did not show any statistically significance according to the groups (*p* \> 0.05) ([Table 6](#tab6){ref-type="table"}).

4. Discussion {#sec4}
=============

PCOS is usually associated with overweight or obesity. This study evaluated nutritional intake, body composition, and energy expenditure of lean PCOS women and compared them with healthy controls. Nutritional status is assessed because the available literature does not provide the assessment of lean women with PCOS. Also, energy expenditure with SenseWear Armband is assessed for the first time in lean PCOS women in this country. SWA is a new and practical tool to measure energy expenditure \[[@B15]\].

Lean PCOS patients have limited data regarding segmental fat distribution in the literature \[[@B9]\]. It has been a reported in a study that women with PCOS who are lean had a higher amount of fat which was statistically important and a lower lean body mass than matched healthy controls \[[@B24]\]. Aydin et al. \[[@B11]\] and Good et al. \[[@B25]\] documented also that there were not any difference in body fat distribution and composition between the lean group with PCOS and healthy women \[[@B11], [@B25]\]. In this study, we did not find significant differences in distribution of fat between women with PCOS and controls. Right leg fat mass and right arm fat-free and fat mass showed significant higher measurements in PCOS than controls. More recent cross-sectional studies compared fat distribution by magnetic resonance imaging (MRI) between the lean group with PCOS and controls. The data have shown that lean patients with PCOS have less visceral fat when compared to control patients. Lean patients with PCOS had significantly lower subcutaneous adipose tissue development although height, weight, and BMI did not change significantly \[[@B13]\]. In particular, without change in weight, the body composition of women who exercise regularly may vary with increasing in lean body mass and low fat mass. Increased lean body mass increases resting energy consumption and can help to improve parameters such as hormonal and metabolic parameters in women with PCOS \[[@B26]\]. It has been observed that women with PCOs who are lean had lower caloric intake than healthy lean women, but found harder to maintain weight \[[@B13]\]. Our results indicate in this study that lean PCOs women had similar energy intake but significantly lower protein intake than controls (%12.73 ± 1.98; 14.39 ± 2.69, respectively). This result may mean that they ingest other macronutrients especially carbohydrates or fats higher than controls. Studies have shown there may not be an optimal diet or macronutrient composition for PCOS \[[@B4], [@B27]\]. It was revealed in a study by Nizareddin et al. (2018) that diet consumed by PCOS subjects was not a balanced one. Though intake of cereals, legumes, dairy products, meats, fats, and sugars were satisfactorily meeting the recommended dietary intake, unfortunately intake of roots, tubers, green leafy, and other vegetables and fruits were poorly met (Nizaruddin et al., 2018). On the contrary, it is reported in another study that there is no difference in macronutrient and energy intake between the two groups \[[@B28]\]. However, a study argued that the usual dietary macronutrient intake in women with PCOS did not show a difference in terms of the age-matched control group \[[@B15]\], and another study concluded that PCOS was affected by nutritional status \[[@B29]\].

In the present study, AEE measurement, PAD measurement, and step measurement of lean PCOS were lower than the control group. According to some research studies, there is no difference in energy or nutritional intake. Macro- or micronutrient intake or PA did not make a difference between the lean or overweight group with the PCOS or control \[[@B30]\]. Only one study which used SWA for the first time in PCOS population found resting metabolic rate measurements similar to the control group \[[@B15]\] which is similar to our data. In one of the PCOS studies, it was found that decreased BMR is shown, especially in women with insulin resistance. It is stated that these individuals should limit their energy intake and increase their energy expenditure by doing exercise to maintain their body weight \[[@B31]\]. Due to lack of available trials, it was not possible to compare energy consumption with SWA in lean patients.

5. Conclusions {#sec5}
==============

PCOS in lean women is seen uniquely and have different phenotypic, metabolic, hematologic, and neurologic characteristics than obese participants with PCOS. In conclusion, nonobese women with PCOS had similar body composition compared to age- and BMI-matched healthy controls. Small sample size is the limitation of our study, and it cannot be extrapolated to all populations as it was conducted in a single research facility. As in any study that uses food record data, there is potential for inaccurate reporting. The results in this study emphasizes no differences between dietary intake; however, protein consumption was significantly lower in PCOS patients \[[@B32]\].
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###### 

Evaluation of some anthropometric measurements of PCOS and the control group.

  Variables       Groups            Mean ± SD          Min-max      Median   ^a^ *p*
  --------------- ----------------- ------------------ ------------ -------- -----------
  Age (year)      PCOS              22.03 ± 4.21       17--34       21       **0.720**
  Control         21.71 ± 2.67      18--33             21                    
                                                                             
  Height (cm)     PCOS              162.70 ± 7.10      149--183     164      **0.415**
  Control         161.42 ± 5.13     154--174           161                   
                                                                             
  Weight (kg)     PCOS              60.10 ± 10.43      42.5--90.7   59.9     **0.069**
  Control         56.01 ± 6.68      42.7--72.1         55.2                  
                                                                             
  BMI (kg/m^2^)   PCOS              22.64 ± 3.64       16.6--29.5   21.2     **0.185**
  Control         21.55 ± 2.77      17--27.4           21                    
                                                                             
  BMR (kcal)      PCOS              1345.85 ± 110.68   1112--1558   1325     **0.103**
  Control         1304.81 ± 85.03   1096--1508         1292                  

^a^Student\'s *t*-test.

###### 

Total body composition analyses.

  Variables       Groups           Mean ± SD        Min-max      Median   ^a^ *p*
  --------------- ---------------- ---------------- ------------ -------- --------------
  FM (%)          PCOS             27.23 ± 6.9      15.7--40.1   27.4     0.089
  Control         24.53 ± 5.51     14.5--37         24.2                  
                                                                          
  FM (kg)         PCOS             16.85 ± 6.76     7.3--32      15.9     **0.050^∗^**
  Control         13.99 ± 4.69     7.1--24.7        13                    
                                                                          
  FFM (kg)        PCOS             42.95 ± 3.66     34.6--49     42.1     0.058
  Control         40.85 ± 4.85     18.8--48         41.3                  
                                                                          
  TBW (kg)        PCOS             40.68 ± 53.62    25.3--339    30.8     0.300
  Control         30.61 ± 2.14     24.9--35.7       30.5                  
                                                                          
  Impedance (Ω)   PCOS             705.63 ± 76.27   550--855     682.5    0.427
  Control         720.81 ± 74.26   578--929         709                   

^a^Student\'s *t-*test, ^*∗*^*p* \< 0.05, FM : fat mass, FFM : fat-free mass, and TBW : total body water.

###### 

Segmental body composition measurements.

  Measurements     Groups         Mean ± SD      Min-max      Median   ^a^ *p*
  ---------------- -------------- -------------- ------------ -------- --------------
  RL_FM (%)        PCOS           32.01 ± 5.25   23.4--40.2   32.9     0.070
  Control          29.88 ± 3.76   22.6--37.7     29.6                  
  RL_FM (kg)       PCOS           3.59 ± 1.05    2.1--5.7     3.5      **0.035^∗^**
  Control          3.12 ± 0.65    1.9--4.4       3                     
  RL_FFM           PCOS           7.43 ± 0.66    6--8.8       7.35     0.206
  Control          7.23 ± 0.52    5.9--8.5       7.1                   
  LL_FM (%)        PCOS           31.75 ± 5.53   22.5--40     32.1     0.150
  Control          30.04 ± 3.56   23--36.9       29.4                  
  LL_FM (kg)       PCOS           3.5 ± 1.06     2--5.5       3.4      0.231
  Control          3.19 ± 0.97    1.9--7.1       2.9                   
  LL_FFM (kg)      PCOS           7.3 ± 0.66     5.9--8.8     7.2      0.080
  Control          7.04 ± 0.48    5.8--8.3       6.9                   
  RA_FAT (%)       PCOS           28.44 ± 7.86   13.7--44.9   26.9     0.035^∗^
  Control          24.02 ± 8.47   0.9--37.5      24.3                  
  RA_FM (kg)       PCOS           0.85 ± 0.38    0.30--1.80   0.75     0.249
  Control          0.74 ± 0.32    0.30--1.90     0.80                  
  RA_FFM (kg)      PCOS           2.01 ± 0.22    1.5--2.5     2        0.040^∗^
  Control          1.91 ± 0.15    1.5--2.2       1.9                   
  LA_FAT (%)       PCOS           29.37 ± 7.71   14.8--43.7   28.65    0.070
  Control          25.81 ± 7.59   0.9--38.6      25.8                  
  LA_FM (kg)       PCOS           0.89 ± 0.41    0.3--1.9     0.75     0.212
  Control          0.77 ± 0.34    0.3--1.9       0.7                   
  LA_FFM (kg)      PCOS           2.01 ± 0.26    1.4--2.5     2        0.070
  Control          1.91 ± 0.18    1.4--2.3       1.9                   
  TRUNK_FAT (%)    PCOS           23.42 ± 8.37   9.2--40      22.75    0.126
  Control          20.31 ± 7.5    7.2--42.1      19.1                  
  TRUNK_FM (kg)    PCOS           7.9 ± 4.02     2--17.4      6.6      0.080
  Control          6.35 ± 2.8     1.9--13.5      5.5                   
  TRUNK_FFM (kg)   PCOS           24.16 ± 2.04   19.8--28.4   23.7     0.075
  Control          23.31 ± 1.68   18.5--26.7     23.1                  

^a^Student\'s *t-*test, ^*∗*^*p* \< 0.05, RL : right leg, LL : left leg, RA : right arm, and LA : left arm.

###### 

Armband metabolic Holter equipment.

  Variable                Groups              Mean ± SD           Min-max       Median   ^a^ *p*
  ----------------------- ------------------- ------------------- ------------- -------- ---------------
  TEE (kcal)              PCOS                2128.84 ± 289.91    1698--2880    2100     0.957
  Control                 2124.66 ± 314.66    831--2502           2158                   
  PAD (hour)              PCOS                1.40 ± 0.87         0.16--3.33    1.23     **0.002^∗∗^**
  Control                 2.18 ± 0.99         0.12--4.24          2.08                   
  AEE (kcal)              PCOS                372.35 ± 198.33     70--783       342      **0.018^∗^**
  Control                 494.1 ± 186.5       48--892             507                    
  Steps                   PCOS                9370.03 ± 3587.49   4004--19550   8583     **0.013^∗^**
  Control                 11730.9 ± 3564.31   3200--19550         12191                  
  Sleep duration (hour)   PCOS                5.67 ± 1.23         2.43--7.58    5.52     0.185
  Control                 6.09 ± 1.19         2.43--8.35          6.26                   
  Average METs            PCOS                1.49 ± 0.17         1.2--1.9      1.50     0.115
  Control                 1.78 ± 1.01         1.2--7              1.60                   
  On-body duration (h)    PCOS                22.55 ± 2.04        15.27--24     23.45    0.581
  Control                 22.21 ± 2.71        15.29--24           23.39                  

^a^Student\'s *t-*test, ^*∗∗*^*p* \< 0.01, ^*∗*^*p* \< 0.05, TEE : total energy expenditure, PAD : physical activity duration, AEE : average energy expenditure, and METs : metabolic equivalents.

###### 

Daily energy intake and macronutrient components of PCOS and control.

  Macronutrients             Groups             Mean ± SD          Min-max          Median    ^a^ *p*
  -------------------------- ------------------ ------------------ ---------------- --------- --------------
  Energy intake (kcal)       PCOS               1907.78 ± 559.71   1176--3431       1788.21   **0.484**
  Control                    1814.25 ± 476.36   993--2845          1751.45                    
  Water (g)                  PCOS               1582.82 ± 606.21   426.3--3159.82   1525.38   **0.946**
  Control                    1595.13 ± 785.33   436.61--3345.1     1290.49                    
  Total protein (g)          PCOS               58.45 ± 15.38      32.36--101.52    57.04     **0.311**
  Control                    62.29 ± 13.96      30.09--86.57       63.21                      
  Total protein (%)          PCOS               12.73 ± 1.98       9--16            12.5      **0.008^∗^**
  Control                    14.39 ± 2.69       10--19             14                         
  Total fat (g)              PCOS               83.51 ± 34.74      34.22--205.62    72.84     **0.421**
  Control                    77.28 ± 24.58      43.8--137.55       73.43                      
  Total fat (%)              PCOS               38.1 ± 6.2         26--53           37        **0.906**
  Control                    37.9 ± 6.68        27--50             37                         
  Total CHO (g)              PCOS               225.43 ± 61.07     147.76--389.99   205.64    **0.454**
  Control                    213.19 ± 65.74     90.55--346.6       195.95                     
  Total CHO (%)              PCOS               49 ± 6.26          35--59           49        **0.449**
  Control                    47.77 ± 6.3        35--59             46                         
  Dietary fiber (g)          PCOS               20.55 ± 7.21       11.56--38.02     18.45     **0.498**
  Control                    21.76 ± 6.67       8.28--34.48        20.41                      
  PUFA (g)                   PCOS               21.58 ± 12.65      5.44--61.27      18.49     **0.605**
  Control                    20.07 ± 9.83       3.29--47.93        19.83                      
  Dietary cholesterol (mg)   PCOS               212.97 ± 81.26     46.54--411.6     212.32    **0.624**
  Control                    225.07 ± 108.35    98.67--606         207.82                     

^a^Student\'s *t*-test, ^*∗∗*^*p* \< 0.01.

###### 

Daily micronutrient composition of PCOS and control.

  Micronutrients      Groups             Mean ± SD           Min-max            Median    ^a^ *p*
  ------------------- ------------------ ------------------- ------------------ --------- -----------
  Vit A (mg)          PCOS               1231.37 ± 1314.54   343.02--7292.16    783.11    **0.766**
  Control             1153.14 ± 613.51   524.97--2638.29     933.59                       
  *β*-Carotene (mg)   PCOS               3.09 ± 2.76         0.45--15.13        2.44      **0.858**
  Control             3.21 ± 2.51        0.63--11.07         2.49                         
  Vit E eq (mg)       PCOS               21.93 ± 11.08       6.9--55.19         20.15     **0.355**
  Control             19.5 ± 9.23        5.24--51.86         19.9                         
  Vit B~1~ (mg)       PCOS               0.82 ± 0.31         0.48--2.11         0.74      **0.771**
  Control             0.85 ± 0.24        0.37--1.3           0.82                         
  Vit B~2~ (mg)       PCOS               1.1 ± 0.25          0.67--1.59         1.07      **0.068**
  Control             1.25 ± 0.36        0.62--2.07          1.14                         
  Vit B~6~ (mg)       PCOS               1.29 ± 0.34         0.81--2.1          1.26      **0.126**
  Control             1.55 ± 0.85        0.81--5.6           1.35                         
  Total FA (mg)       PCOS               280.41 ± 82.82      175.26--561.27     275.87    **0.489**
  Control             295.95 ± 90.99     180.31--471.01      279.53                       
  Vit C (mg)          PCOS               99.09 ± 41.29       37.47--229.34      85.95     **0.114**
  Control             117.3 ± 47.19      13.25--217.79       117.9                        
  Na (mg)             PCOS               1598.15 ± 627.72    564.71--2584.83    1456.11   **0.332**
  Control             1782.13 ± 823.86   791.41--4653.74     1742.96                      
  K (mg)              PCOS               2215.3 ± 560.02     1251.17--3348.04   2092.56   **0.079**
  Control             2485.33 ± 617.79   1524.26--3730.24    2357.49                      
  Ca (mg)             PCOS               599.83 ± 187.51     281.67--996.61     565.92    **0.176**
  Control             671.23 ± 217.76    351.75--1131.76     629.73                       
  Mg (mg)             PCOS               254.51 ± 92.81      150.51--526.8      232.48    **0.793**
  Control             260.42 ± 82.1      138.81--493.72      245.42                       
  P (mg)              PCOS               956.58 ± 267.85     481.5--1689.12     940.92    **0.246**
  Control             1036.57 ± 264.9    438.32--1626.59     1025.1                       
  Fe (mg)             PCOS               10.42 ± 3.07        6.21--18.42        9.58      **0.210**
  Control             11.49 ± 3.51       5.12--19.38         11.16                        
  Zinc (mg)           PCOS               8.91 ± 2.67         5.25--15.75        8.59      **0.452**
  Control             9.41 ± 2.51        3.87--14.72         9.19                         

^a^Student\'s *t*-test.

[^1]: Academic Editor: Luigi Schiavo
